Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation (STRATUS-EU)
This study has been completed.
Study NCT00464165.   Last updated on April 20, 2007.
Information provided by Sanofi-Aventis
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smoking Cessation
Additional conditions recognized in this trial
Smoking
More general conditions related to this trial
Habits
Interventions listed in this trial
rimonabant
Sponsors listed in this trial
Sanofi-Aventis


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services